India’s Cipla Launches Copy Of GSK’s Top Asthma Drug In Germany, Sweden – Business Insider


Economic Times

India's Cipla Launches Copy Of GSK's Top Asthma Drug In Germany, Sweden
Business Insider
MUMBAI (Reuters) – India's Cipla Ltd has launched an anti-asthma inhaler in Germany and Sweden that is a generic version of GlaxoSmithKline Plc's Advair, a move that will further dent sales of the British firm's top-selling product. Cipla's drug will
Cipla launches Serroflo in Germany and Sweden with affordable high quality pharmabiz.com

all 6 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.